Gaby Galindo
Medical · Folsom, CANPI 1104254671
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,303, 2.1 times the $625 reported in 2021.
Across 167 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$678
- Madrigal Pharmaceuticals$644
- GSK$567
- Novo Nordisk$406
- Lilly USA, LLC$266
- Nestle Healthcare Nutrition Inc.$225
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $678 |
| Madrigal Pharmaceuticals | 16 | $644 |
| GSK | 20 | $567 |
| Novo Nordisk | 11 | $406 |
| Lilly USA, LLC | 8 | $266 |
| Nestle Healthcare Nutrition Inc. | 9 | $225 |
| Amgen | 9 | $189 |
| Kowa Pharmaceuticals America, Inc. | 7 | $162 |
| Johnson & Johnson | 2 | $158 |
| Pfizer | 7 | $154 |
| Merck | 6 | $136 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Exact Sciences | 5 | $113 |
| Philips North America LLC | 1 | $101 |
| Bayer | 4 | $99 |
| Biohaven Pharmaceuticals, Inc. | 4 | $80 |
| Astellas Pharma US Inc | 2 | $78 |
| Novartis | 3 | $69 |
| AstraZeneca | 4 | $68 |
| Seqirus USA Inc | 2 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Acerus Pharmaceuticals Corporation | 2 | $29 |
| Verity Pharmaceuticals Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Eisai Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,573 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Teriparatide | 12 | $19,521 |
| OzempicSemaglutide | 19 | $18,014 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,907 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 30 | $3,726 |
| Atorvastatin Calcium | 182 | $2,149 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $1,583 |
| SynthroidLevothyroxine Sodium | 23 | $1,477 |
| Omeprazole | 65 | $1,476 |
| Levothyroxine Sodium | 81 | $1,194 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $1,053 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $1,017 |
| ValacyclovirValacyclovir Hcl | 13 | $933 |
| Lisinopril | 67 | $906 |
| Metoprolol Succinate | 34 | $869 |
| Amlodipine Besylate | 80 | $803 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $406 | $18,01419 claims |
| GSKBreo Ellipta | $567 | $4,90712 claims |
| AbbVieSynthroid, Armour Thyroid | $678 | $1,88436 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.
Other medical in Folsom
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
- Cheryl KyinnSan Diego$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.